Sunvozertinib Superior to Chemotherapy in First-Line EGFR Exon20ins Lung Cancer
At the 2026 American Society of Clinical Oncology (ASCO) annual meeting, researchers presented data demonstrating that sunvozertinib significantly improves progression-free survival compared to traditional platinum-based chemotherapy in patients with advanced ... Read More